Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Now that we’re all AEZS shareholders
View:
Post by lscfa on Mar 12, 2024 5:58pm

Now that we’re all AEZS shareholders

How about a damn update....

"We expect enrollment in our DETECT-trial to be completed around the end of 2023"
Comment by prophetoffactz on Mar 12, 2024 6:38pm
What do you think the upfront, milestone and royalties will be for a new North American deal? They are also pursuing a potential Asian and South American deal. How likely and what terms? The pediatric trial that was expected to be fully enrolled by the end of the year is set up to potentially prove the diagnostic as a standalone test. Currently two tests are required for diagnosis. Imagine being ...more  
Comment by prophetoffactz on Mar 12, 2024 6:43pm
I wonder how much Gilles knows... Clinicaltrials.gov: Study Details | A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is | ClinicalTrials.gov Last Update Posted2023-05-06 Primary Completion (Estimated)  2023-09 Study Completion (Estimated)  2023-09 Enrollment  ...more  
Comment by scarface9 on Mar 13, 2024 8:28am
Will there be a restructuring and lay offs at head office. Only one CEO, CFO needed now, so somebody has to go. Plus a lot of other positions will now be redundant and can be consolidated. 
Comment by prophetoffactz on Mar 13, 2024 8:39am
With the completion of AEZS's diagnostic clinical trial the costs for the clinical trial for the test falls off. They can streamline human infrastructure as only one CEO, CFO, VP Business Development, etc., and IR function is needed. The collective number of individuals on the Board of Directors shrinks saving money. The two companies can also share human infrastrucutre as human trials advance ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities